Recruiting
Investigational
A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments
Investigational
- Substances:–
Countries:
Spain
Spain- Participants:18–64 years
Find therapies in clinical trials near you – page 41
- recruiting
- 3 983
- countries
- 28
- conditions
- 2 109
3 983 trials recruiting28 European countries2 109 conditions coveredUpdated today
10 385 trials match your criteria
Recruiting
Non-small cell lung cancer
RecruitingA study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer
Registered drugNo placebo
A study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer
Registered drugNo placebo
- Disease:Non-small cell lung cancer
- Substances:Infliximab
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Infliximab
Recruiting
Pneumonia bacterial
RecruitingA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
Registered drug
A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
Registered drug
- Disease:Pneumonia bacterial
- Substances:Saline
Countries:
Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Saline
Recruiting
Breast cancer+1
RecruitingZanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults
Registered drugNo placebo
Zanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults
Registered drugNo placebo
- Disease:Breast cancerHER2 positive breast cancer
- Substances:TucatinibZanidatamab+1
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Tucatinib
Recruiting
Bacterial infection
RecruitingEarly Stopping of Antibiotic Treatment in Children with Cancer and Febrile Neutropenia
Registered drugNo placebo
Early Stopping of Antibiotic Treatment in Children with Cancer and Febrile Neutropenia
Registered drugNo placebo
- Disease:Bacterial infection
- Substances:–
Countries:Spain
Spain- Participants:0–17 years · 18–64 years
Recruiting
Graves' disease
RecruitingLong-Term Study of Imeroprubart in Adults With Graves' Disease
InvestigationalNo placebo
Long-Term Study of Imeroprubart in Adults With Graves' Disease
InvestigationalNo placebo
- Disease:Graves' disease
- Substances:–
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
Recruiting
Neoplasm
RecruitingVolrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma
Registered drugNo placebo
Volrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma
Registered drugNo placebo
- Disease:Neoplasm
- Substances:InfliximabVolrustomig
Countries:
Germany
Germany- Participants:18–64 years
- Substances:Infliximab
Recruiting
Osteochondrodysplasia
RecruitingBMN 333 Versus Vosoritide in Children With Achondroplasia
Registered drugNo placebo
BMN 333 Versus Vosoritide in Children With Achondroplasia
Registered drugNo placebo
- Disease:Osteochondrodysplasia
- Substances:–
Countries:France
France- Participants:0–17 years
Recruiting
Persistent corneal epithelial defect
RecruitingCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
Registered drug
Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
Registered drug
- Disease:Persistent corneal epithelial defect
- Substances:–
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
Recruiting
Inflammatory bowel disease+1
RecruitingModafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease
Registered drug
Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease
Registered drug
- Disease:Inflammatory bowel diseaseChronic fatigue syndrome
- Substances:–
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
Recruiting
Insomnia+1
RecruitingDaridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia
Registered drug
Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia
Registered drug
- Disease:InsomniaMajor depression
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
Recruiting
Dry age-related macular degeneration
RecruitingFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
Investigational
FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
Investigational
- Disease:Dry age-related macular degeneration
- Substances:–
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years